BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Edmonds S, Volpe A, Shmeeda H, Parente-Pereira AC, Radia R, Baguña-Torres J, Szanda I, Severin GW, Livieratos L, Blower PJ, Maher J, Fruhwirth GO, Gabizon A, T M de Rosales R. Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines. ACS Nano 2016;10:10294-307. [PMID: 27781436 DOI: 10.1021/acsnano.6b05935] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Ahmadi M, Emzhik M, Mosayebnia M. Nanoparticles labeled with gamma-emitting radioisotopes: an attractive approach for in vivo tracking using SPECT imaging. Drug Deliv Transl Res 2023. [PMID: 36811810 DOI: 10.1007/s13346-023-01291-1] [Reference Citation Analysis]
2 González-méndez I, Sorroza-martínez K, Ruiu A, Rivera E. Carbon nanotubes for anticancer therapy: new trends and innovations. Emerging Applications of Carbon Nanotubes in Drug and Gene Delivery 2023. [DOI: 10.1016/b978-0-323-85199-2.00005-4] [Reference Citation Analysis]
3 Hu X, Ha E, Ai F, Huang X, Yan L, He S, Ruan S, Hu J. Stimulus-responsive inorganic semiconductor nanomaterials for tumor-specific theranostics. Coordination Chemistry Reviews 2022;473:214821. [DOI: 10.1016/j.ccr.2022.214821] [Reference Citation Analysis]
4 Gawne PJ, Pinto SMA, Nielsen KM, Keeling GP, Pereira MM, T M de Rosales R. Microwave-assisted synthesis of [(52)Mn]Mn-porphyrins: Applications in cell and liposome radiolabelling. Nucl Med Biol 2022;114-115:6-17. [PMID: 36088876 DOI: 10.1016/j.nucmedbio.2022.08.006] [Reference Citation Analysis]
5 Poletto G, Evangelista L, Venturini F, Gramegna F, Seno F, Moro S, Vettor R, Realdon N, Cecchin D. Nanoparticles and Radioisotopes: A Long Story in a Nutshell. Pharmaceutics 2022;14:2024. [DOI: 10.3390/pharmaceutics14102024] [Reference Citation Analysis]
6 Poletto G, Cecchin D, Bartoletti P, Venturini F, Realdon N, Evangelista L. Radionuclide Delivery Strategies in Tumor Treatment: A Systematic Review. Curr Issues Mol Biol 2022;44:3267-82. [PMID: 35892711 DOI: 10.3390/cimb44080225] [Reference Citation Analysis]
7 Wang Z, Li J, Lin G, He Z, Wang Y. Metal complex-based liposomes: Applications and prospects in cancer diagnostics and therapeutics. J Control Release 2022;348:1066-88. [PMID: 35718211 DOI: 10.1016/j.jconrel.2022.06.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ramezani Farani M, Aminzadeh Jahromi N, Ali V, Ebrahimpour A, Salehian E, Shafiee Ardestani M, Seyedhamzeh M, Ahmadi S, Sharifi E, Ashrafizadeh M, Rabiee N, Makvandi P. Detection of Dopamine Receptors Using Nanoscale Dendrimer for Potential Application in Targeted Delivery and Whole-Body Imaging: Synthesis and In Vivo Organ Distribution. ACS Appl Bio Mater . [DOI: 10.1021/acsabm.2c00118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Poley M, Mora-Raimundo P, Shammai Y, Kaduri M, Koren L, Adir O, Shklover J, Shainsky-Roitman J, Ramishetti S, Man F, de Rosales RTM, Zinger A, Peer D, Ben-Aharon I, Schroeder A. Nanoparticles Accumulate in the Female Reproductive System during Ovulation Affecting Cancer Treatment and Fertility. ACS Nano 2022. [PMID: 35293714 DOI: 10.1021/acsnano.1c07237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Peña Q, Wang A, Zaremba O, Shi Y, Scheeren HW, Metselaar JM, Kiessling F, Pallares RM, Wuttke S, Lammers T. Metallodrugs in cancer nanomedicine. Chem Soc Rev 2022. [PMID: 35262108 DOI: 10.1039/d1cs00468a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
11 Chen X, Niu W, Du Z, Zhang Y, Su D, Gao X. 64Cu radiolabeled nanomaterials for positron emission tomography (PET) imaging. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.02.070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yilmaz D, Sharp PS, Main MJ, Simpson PB. Advanced molecular imaging for the characterisation of complex medicines. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Khan AA, Man F, Faruqu FN, Kim J, Al-Salemee F, Carrascal-Miniño A, Volpe A, Liam-Or R, Simpson P, Fruhwirth GO, Al-Jamal KT, T M de Rosales R. PET Imaging of Small Extracellular Vesicles via [89Zr]Zr(oxinate)4 Direct Radiolabeling. Bioconjug Chem 2022. [PMID: 35224973 DOI: 10.1021/acs.bioconjchem.1c00597] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sguizzato M, Pula W, Bordin A, Pagnoni A, Drechsler M, Marvelli L, Cortesi R. Manganese in Diagnostics: A Preformulatory Study. Pharmaceutics 2022;14:108. [PMID: 35057004 DOI: 10.3390/pharmaceutics14010108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Figueroa-pizano M, Carvajal-millan E. Nanovesicles for image-guided drug delivery. Systems of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91864-0.00008-5] [Reference Citation Analysis]
16 Forsyth CM, Greenhill NB, Junk PC, Deacon GB. Elucidating structural patterns in hydrogen bond dense materials: a study of ammonium salts of (4‐aminium‐1‐hydroxybutylidine)‐1,1‐bisphosphonic acid. Zeitschrift anorg allge chemie. [DOI: 10.1002/zaac.202100305] [Reference Citation Analysis]
17 Southcott L, Orvig C. Inorganic radiopharmaceutical chemistry of oxine. Dalton Trans 2021;50:16451-8. [PMID: 34709268 DOI: 10.1039/d1dt02685b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chen Y, Wang T, Xie P, Song Y, Wang J, Cai Z. Mass spectrometry imaging revealed alterations of lipid metabolites in multicellular tumor spheroids in response to hydroxychloroquine. Anal Chim Acta 2021;1184:339011. [PMID: 34625248 DOI: 10.1016/j.aca.2021.339011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 Maiques O, Fanshawe B, Crosas-Molist E, Rodriguez-Hernandez I, Volpe A, Cantelli G, Boehme L, Orgaz JL, Mardakheh FK, Sanz-Moreno V, Fruhwirth GO. A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma. Br J Cancer 2021;125:699-713. [PMID: 34172930 DOI: 10.1038/s41416-021-01442-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
20 Sta Maria NS, Khawli LA, Pachipulusu V, Lin SW, Zheng L, Cohrs D, Liu X, Hu P, Epstein AL, Jacobs RE. Spatio-temporal biodistribution of 89Zr-oxine labeled huLym-1-A-BB3z-CAR T-cells by PET imaging in a preclinical tumor model. Sci Rep 2021;11:15077. [PMID: 34302002 DOI: 10.1038/s41598-021-94490-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Mkhatshwa M, Moremi JM, Makgopa K, Manicum AE. Nanoparticles Functionalised with Re(I) Tricarbonyl Complexes for Cancer Theranostics. Int J Mol Sci 2021;22:6546. [PMID: 34207182 DOI: 10.3390/ijms22126546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Khan AA, T M de Rosales R. Radiolabelling of Extracellular Vesicles for PET and SPECT imaging. Nanotheranostics 2021;5:256-74. [PMID: 33654653 DOI: 10.7150/ntno.51676] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
23 Zhou J, Rao L, Yu G, Cook TR, Chen X, Huang F. Supramolecular cancer nanotheranostics. Chem Soc Rev 2021;50:2839-91. [PMID: 33524093 DOI: 10.1039/d0cs00011f] [Cited by in Crossref: 118] [Cited by in F6Publishing: 132] [Article Influence: 59.0] [Reference Citation Analysis]
24 Witney TH, Blower PJ. The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy. Cancer Imaging 2021;21:18. [PMID: 33516256 DOI: 10.1186/s40644-021-00385-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Pellico J, Gawne PJ, T M de Rosales R. Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev 2021;50:3355-423. [PMID: 33491714 DOI: 10.1039/d0cs00384k] [Cited by in Crossref: 50] [Cited by in F6Publishing: 60] [Article Influence: 25.0] [Reference Citation Analysis]
26 Oliveri V. Biomedical applications of copper ionophores. Coordination Chemistry Reviews 2020;422:213474. [DOI: 10.1016/j.ccr.2020.213474] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
27 Zhang X, Chen J, Jiang Q, Ding X, Li Y, Chen C, Yang W, Chen S. Highly biosafe biomimetic stem cell membrane-disguised nanovehicles for cartilage regeneration. J Mater Chem B 2020;8:8884-93. [PMID: 33026410 DOI: 10.1039/d0tb01686a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
28 Man F, Khan AA, Carrascal-Miniño A, Blower PJ, T M de Rosales R. A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)3. Nucl Med Biol 2020;90-91:31-40. [PMID: 32979725 DOI: 10.1016/j.nucmedbio.2020.09.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
29 Coenen HH, Ermert J. Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18. Nucl Med Biol 2021;92:241-69. [PMID: 32900582 DOI: 10.1016/j.nucmedbio.2020.07.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
30 Siafaka PI, Okur NÜ, Karantas ID, Okur ME, Gündoğdu EA. Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities. Asian J Pharm Sci 2021;16:24-46. [PMID: 33613728 DOI: 10.1016/j.ajps.2020.03.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 14.7] [Reference Citation Analysis]
31 Iafrate M, Fruhwirth GO. How Non-invasive in vivo Cell Tracking Supports the Development and Translation of Cancer Immunotherapies. Front Physiol 2020;11:154. [PMID: 32327996 DOI: 10.3389/fphys.2020.00154] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
32 Ashmore-Harris C, Iafrate M, Saleem A, Fruhwirth GO. Non-invasive Reporter Gene Imaging of Cell Therapies, including T Cells and Stem Cells. Mol Ther 2020;28:1392-416. [PMID: 32243834 DOI: 10.1016/j.ymthe.2020.03.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
33 Gawne PJ, Clarke F, Turjeman K, Cope AP, Long NJ, Barenholz Y, Terry SYA, de Rosales RTM. PET Imaging of Liposomal Glucocorticoids using 89Zr-oxine: Theranostic Applications in Inflammatory Arthritis. Theranostics 2020;10:3867-79. [PMID: 32226525 DOI: 10.7150/thno.40403] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
34 Zhu J, Zhang H, Chen K, Li Y, Yang Z, Chen S, Zheng X, Zhou X, Jiang ZX. Peptidic Monodisperse PEG "Comb" as Multifunctional "Add-On" Module for Imaging-Traceable and Thermo-Responsive Theranostics. Adv Healthc Mater 2020;9:e1901331. [PMID: 31851435 DOI: 10.1002/adhm.201901331] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
35 Imberti C, Sadler PJ. 150 years of the periodic table: New medicines and diagnostic agents. Medicinal Chemistry. Elsevier; 2020. pp. 3-56. [DOI: 10.1016/bs.adioch.2019.11.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
36 Gabizon AA, de Rosales RTM, La-Beck NM. Translational considerations in nanomedicine: The oncology perspective. Adv Drug Deliv Rev 2020;158:140-57. [PMID: 32526450 DOI: 10.1016/j.addr.2020.05.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
37 La-Beck NM, Liu X, Shmeeda H, Shudde C, Gabizon AA. Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment. Semin Cancer Biol 2021;68:175-85. [PMID: 31874280 DOI: 10.1016/j.semcancer.2019.12.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
38 van der Meel R, Sulheim E, Shi Y, Kiessling F, Mulder WJM, Lammers T. Smart cancer nanomedicine. Nat Nanotechnol 2019;14:1007-17. [PMID: 31695150 DOI: 10.1038/s41565-019-0567-y] [Cited by in Crossref: 493] [Cited by in F6Publishing: 513] [Article Influence: 123.3] [Reference Citation Analysis]
39 Ding Z, Xu K. Recent progress in imaging technology combined with nanomaterials for medical applications. Micro & Nano Letters 2019;14:1263-7. [DOI: 10.1049/mnl.2019.0221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Ge J, Zhang Q, Zeng J, Gu Z, Gao M. Radiolabeling nanomaterials for multimodality imaging: New insights into nuclear medicine and cancer diagnosis. Biomaterials 2020;228:119553. [PMID: 31689672 DOI: 10.1016/j.biomaterials.2019.119553] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 17.3] [Reference Citation Analysis]
41 Cortezon-tamarit F, Baryzewska A, Lledos M, Pascu S. Zirconium-89 radio-nanochemistry and its applications towards the bioimaging of prostate cancer. Inorganica Chimica Acta 2019;496:119041. [DOI: 10.1016/j.ica.2019.119041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Peltek OO, Muslimov AR, Zyuzin MV, Timin AS. Current outlook on radionuclide delivery systems: from design consideration to translation into clinics. J Nanobiotechnology 2019;17:90. [PMID: 31434562 DOI: 10.1186/s12951-019-0524-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
43 Grodzinski P, Kircher M, Goldberg M, Gabizon A. Integrating Nanotechnology into Cancer Care. ACS Nano 2019;13:7370-6. [PMID: 31240914 DOI: 10.1021/acsnano.9b04266] [Cited by in Crossref: 74] [Cited by in F6Publishing: 80] [Article Influence: 18.5] [Reference Citation Analysis]
44 Savolainen H, Volpe A, Phinikaridou A, Douek M, Fruhwirth G, de Rosales RTM. 68Ga-Sienna+ for PET-MRI Guided Sentinel Lymph Node Biopsy: Synthesis and Preclinical Evaluation in a Metastatic Breast Cancer Model. Nanotheranostics 2019;3:255-65. [PMID: 31263657 DOI: 10.7150/ntno.34727] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
45 Man F, Gawne PJ, T M de Rosales R. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine. Adv Drug Deliv Rev 2019;143:134-60. [PMID: 31170428 DOI: 10.1016/j.addr.2019.05.012] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 13.8] [Reference Citation Analysis]
46 Fruhwirth GO, Kneilling M, de Vries IJM, Weigelin B, Srinivas M, Aarntzen EHJG. The Potential of In Vivo Imaging for Optimization of Molecular and Cellular Anti-cancer Immunotherapies. Mol Imaging Biol 2018;20:696-704. [PMID: 30030697 DOI: 10.1007/s11307-018-1254-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
47 Man F, Lammers T, T M de Rosales R. Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies. Mol Imaging Biol 2018;20:683-95. [PMID: 30084044 DOI: 10.1007/s11307-018-1255-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 71] [Article Influence: 15.8] [Reference Citation Analysis]
48 Xia Y, Xu C, Zhang X, Ning P, Wang Z, Tian J, Chen X. Liposome-based probes for molecular imaging: from basic research to the bedside. Nanoscale 2019;11:5822-38. [DOI: 10.1039/c9nr00207c] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
49 Dong Z, Feng L, Chao Y, Hao Y, Chen M, Gong F, Han X, Zhang R, Cheng L, Liu Z. Amplification of Tumor Oxidative Stresses with Liposomal Fenton Catalyst and Glutathione Inhibitor for Enhanced Cancer Chemotherapy and Radiotherapy. Nano Lett 2019;19:805-15. [DOI: 10.1021/acs.nanolett.8b03905] [Cited by in Crossref: 240] [Cited by in F6Publishing: 254] [Article Influence: 48.0] [Reference Citation Analysis]
50 Engudar G, Schaarup-Jensen H, Fliedner FP, Hansen AE, Kempen P, Jølck RI, Kjæer A, Andresen TL, Clausen MH, Jensen AI, Henriksen JR. Remote loading of liposomes with a 124I-radioiodinated compound and their in vivo evaluation by PET/CT in a murine tumor model. Theranostics 2018;8:5828-41. [PMID: 30613265 DOI: 10.7150/thno.26706] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
51 Gawne P, Man F, Fonslet J, Radia R, Bordoloi J, Cleveland M, Jimenez-Royo P, Gabizon A, Blower PJ, Long N, de Rosales RTM. Manganese-52: applications in cell radiolabelling and liposomal nanomedicine PET imaging using oxine (8-hydroxyquinoline) as an ionophore. Dalton Trans 2018;47:9283-93. [PMID: 29796500 DOI: 10.1039/c8dt00100f] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
52 Man F, Lim L, Volpe A, Gabizon A, Shmeeda H, Draper B, Parente-Pereira AC, Maher J, Blower PJ, Fruhwirth GO, T M de Rosales R. In Vivo PET Tracking of 89Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal Alendronate. Mol Ther 2019;27:219-29. [PMID: 30429045 DOI: 10.1016/j.ymthe.2018.10.006] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 11.6] [Reference Citation Analysis]
53 Boros E, Packard AB. Radioactive Transition Metals for Imaging and Therapy. Chem Rev 2019;119:870-901. [PMID: 30299088 DOI: 10.1021/acs.chemrev.8b00281] [Cited by in Crossref: 130] [Cited by in F6Publishing: 132] [Article Influence: 26.0] [Reference Citation Analysis]
54 Sun J, Sun L, Li J, Xu J, Wan Z, Ouyang Z, Liang L, Li S, Zeng D. A multi-functional polymeric carrier for simultaneous positron emission tomography imaging and combination therapy. Acta Biomater 2018;75:312-22. [PMID: 29885530 DOI: 10.1016/j.actbio.2018.06.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
55 Volpe A, Kurtys E, Fruhwirth GO. Cousins at work: How combining medical with optical imaging enhances in vivo cell tracking. Int J Biochem Cell Biol 2018;102:40-50. [PMID: 29960079 DOI: 10.1016/j.biocel.2018.06.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
56 Ehlerding EB, Grodzinski P, Cai W, Liu CH. Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics. ACS Nano 2018;12:2106-21. [PMID: 29462554 DOI: 10.1021/acsnano.7b07252] [Cited by in Crossref: 94] [Cited by in F6Publishing: 100] [Article Influence: 18.8] [Reference Citation Analysis]
57 Volpe A, Man F, Lim L, Khoshnevisan A, Blower J, Blower PJ, Fruhwirth GO. Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models. J Vis Exp 2018. [PMID: 29608157 DOI: 10.3791/57088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
58 Aluicio-Sarduy E, Ellison PA, Barnhart TE, Cai W, Nickles RJ, Engle JW. PET radiometals for antibody labeling. J Labelled Comp Radiopharm 2018;61:636-51. [PMID: 29341227 DOI: 10.1002/jlcr.3607] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
59 Adumeau P, Vivier D, Sharma SK, Wang J, Zhang T, Chen A, Agnew BJ, Zeglis BM. Site-Specifically Labeled Antibody-Drug Conjugate for Simultaneous Therapy and ImmunoPET. Mol Pharm 2018;15:892-8. [PMID: 29356543 DOI: 10.1021/acs.molpharmaceut.7b00802] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
60 Chen D, Hong H. Surface Modification of Radionanomedicine. Radionanomedicine 2018. [DOI: 10.1007/978-3-319-67720-0_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
61 Jensen AI, Severin GW, Hansen AE, Fliedner FP, Eliasen R, Parhamifar L, Kjær A, Andresen TL, Henriksen JR. Remote-loading of liposomes with manganese-52 and in vivo evaluation of the stabilities of 52Mn-DOTA and 64Cu-DOTA using radiolabelled liposomes and PET imaging. Journal of Controlled Release 2018;269:100-9. [DOI: 10.1016/j.jconrel.2017.11.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
62 Luo D, Goel S, Liu HJ, Carter KA, Jiang D, Geng J, Kutyreff CJ, Engle JW, Huang WC, Shao S, Fang C, Cai W, Lovell JF. Intrabilayer 64Cu Labeling of Photoactivatable, Doxorubicin-Loaded Stealth Liposomes. ACS Nano 2017;11:12482-91. [PMID: 29195037 DOI: 10.1021/acsnano.7b06578] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 9.3] [Reference Citation Analysis]
63 Pellico J, Llop J, Fernández-Barahona I, Bhavesh R, Ruiz-Cabello J, Herranz F. Iron Oxide Nanoradiomaterials: Combining Nanoscale Properties with Radioisotopes for Enhanced Molecular Imaging. Contrast Media Mol Imaging 2017;2017:1549580. [PMID: 29358900 DOI: 10.1155/2017/1549580] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
64 Lamichhane N, Dewkar GK, Sundaresan G, Mahon RN, Zweit J. [18F]-Fluorinated Carboplatin and [111In]-Liposome for Image-Guided Drug Delivery. Int J Mol Sci 2017;18:E1079. [PMID: 28524076 DOI: 10.3390/ijms18051079] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
65 Li N, Yu Z, Pham TT, Blower PJ, Yan R. A generic 89Zr labeling method to quantify the in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography. Int J Nanomedicine 2017;12:3281-94. [PMID: 28458546 DOI: 10.2147/IJN.S134379] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
66 Andriyanov AV, Portnoy E, Koren E, Inesa S, Eyal S, Goldberg SN, Barenholz Y. Therapeutic efficacy of combined PEGylated liposomal doxorubicin and radiofrequency ablation: Comparing single and combined therapy in young and old mice. J Control Release 2017;257:2-9. [PMID: 28215670 DOI: 10.1016/j.jconrel.2017.02.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]